These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2535245)

  • 1. Susceptibility of gram positive cocci to teicoplanin. Three year survey (1984-1986) at Perugia University.
    Pasticci MB; Baldelli F; Moretti A; Menichetti F; Pauluzzi S
    Boll Ist Sieroter Milan; 1989; 68(1):5-6. PubMed ID: 2535245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
    Kayaokay Y; Hasçelik G; Gür D; Akalin E
    Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretive criteria for the agar diffusion susceptibility test with teicoplanin using the ICS-and DIN-methods, respectively.
    Grimm H; Fell J
    Chemioterapia; 1987 Jun; 6(2 Suppl):119-20. PubMed ID: 2978386
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.
    Jensen KT; Schønheyder H; Pers C; Thomsen VF
    APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surveillance of gram positive cocci susceptibility to betalactams, glycopeptides, and other antimicrobials].
    Giglio MS; Farías O; Lafourcade M; Pinto ME
    Rev Med Chil; 1999 Aug; 127(8):919-25. PubMed ID: 10752252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Brazilian staphylococcal strains to glycopeptides evaluated by different testing methods.
    Ferreira Nunes AP; Martins Teixeira L; Reis Bastos CC; de Souza Fonseca L; Netto dos Santos KR
    Curr Microbiol; 2002 Jun; 44(6):385-90. PubMed ID: 12000986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods.
    Mushtaq S; Warner M; Johnson AP; Livermore DM
    J Antimicrob Chemother; 2004 Sep; 54(3):617-20. PubMed ID: 15321983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Staphylococcus haemolyticus. Bacterial resistance to teicoplanin and associated morpho-structural aspects].
    Giovanetti E; Pugnaloni A; Marinelli F; Biavasco F; Biagini G
    Boll Soc Ital Biol Sper; 1989 Oct; 65(10):975-82. PubMed ID: 2533873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of a commercial microdilution method and a conventional disk diffusion method for determination of antibiograms of gram-positive cocci.
    Newman SS; Roy AF; Luther DG; Hoskins JD; Cox HU; Kearney MT
    Am J Vet Res; 1985 Jan; 46(1):294-7. PubMed ID: 3918490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical factors influencing the bactericidal activity of teicoplanin against staphylococci.
    Pasticci MB; Moretti A; Frongillo RF; Baldelli F; Moretti MV; Pauluzzi S
    Boll Ist Sieroter Milan; 1989; 68(2):101-7. PubMed ID: 2535247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity to vancomycin and teicoplanin of coagulase-negative staphylococci isolated from clinical specimens].
    Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J
    Med Dosw Mikrobiol; 1999; 51(1-2):17-23. PubMed ID: 10865426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci.
    Ravizzola G; Pirali F; Foresti I; Turano A
    Drugs Exp Clin Res; 1987; 13(4):225-9. PubMed ID: 2957187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of resistance to glycopeptide antibiotics in staphylococci.
    Biavasco F; Giovanetti E; Varaldo PE
    J Chemother; 1991 Jan; 3 Suppl 1():166-8. PubMed ID: 12041756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of the susceptibility of staphylococci and enterococci to plycopeptides by the E-test method].
    Plotton N; Cavallo JD; Crenn Y; Meyran M
    Pathol Biol (Paris); 1994 May; 42(5):468-70. PubMed ID: 7824315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening.
    Nunes AP; Teixeira LM; Iorio NL; Bastos CC; de Sousa Fonseca L; Souto-Padrón T; dos Santos KR
    Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activity of glycopeptides on 114 coagulase-negative staphylococci: problems with the teicoplanin diffusion test, "alert" parameters indicating need for MIC determination].
    Jean-Pierre H; Rivière M; Darbas H; Boyer G
    Pathol Biol (Paris); 1993 Jun; 41(6):531-6. PubMed ID: 8247632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.
    Biedenbach DJ; Ross JE; Fritsche TR; Sader HS; Jones RN
    J Clin Microbiol; 2007 Mar; 45(3):998-1004. PubMed ID: 17215346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
    Kenny MT; Dulworth JK; Brackman MA
    Diagn Microbiol Infect Dis; 1991; 14(1):29-31. PubMed ID: 1826479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of staphylococci and enterococci to glycopeptides comparison of 3 test methods.
    Jansen B; Schumacher-Perdreau F; Pulverer G
    Zentralbl Bakteriol; 1995 Oct; 282(4):402-8. PubMed ID: 9810663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.